Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06516458

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

Development of Camera Based Gait Deviation Index for Persons With Multiple Sclerosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Shirley Ryan AbilityLab · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).

Detailed description

In rehabilitation in general, in order to track patients' progress and provide next steps, there is a need for easily obtainable, understandable, and objective measures of ability. Currently, there is no measure that clinicians can utilize to determine walking quality. While Gait Deviation Index has been validated and can reliably be used in adults who experienced a Spinal Cord Injury, it has not yet been validated in people with MS. After the MS-specific GDI is developed from this study, therapists and clinicians will be able use it as a reliable progress measure. Which may lead to the delivery of more effective therapy for patients with MS. Here we plan to measure body position with camera based tracking during your gait cycle.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCamera Based Kinematic AnalysisObservational Study using Camera Based, Marker Less Kinematic Analysis of gait quality of persons with Multiple Sclerosis

Timeline

Start date
2024-07-01
Primary completion
2025-07-01
Completion
2026-07-01
First posted
2024-07-24
Last updated
2024-07-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06516458. Inclusion in this directory is not an endorsement.